Approval is based on results from the TROPION-Breast01 Phase III trial, in which Datroway demonstrated a significant reduction in the risk of disease progression or death in patients with previously ...
AstraZeneca AZN announced that the FDA has approved its antibody-drug conjugate (ADC), datopotamab deruxtecan (or Dato-DXd), ...
The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...
IonQ's strong revenue growth and partnerships with industry leaders are promising, but high operating expenses and reliance ...
Sir Chris Whitty tells the Covid-19 Inquiry the NHS has 'slipped backwards' since the pandemic at sharing vital patient data, ...
Shares of AstraZeneca PLC AZN slid 1.32% to £107.94 Monday, on what proved to be an all-around great trading session for the ...
A HUGE study that has been launched to find treatments for diseases by measuring how the proteins circulating in our bodies ...
Sachin Jain, an analyst from Bank of America Securities, reiterated the Buy rating on AstraZeneca (AZN – Research Report). The associated price ...
Dr. Patrick Hemmons travelled to Seattle, Wash., to get an RSV shot for his daughter. He says he hopes to see ...
The approval of Calquence marks the first and only BTK inhibitor approved for the first-line treatment of MCL in the US.
The broader Topix index settled 1.19 percent higher at 2,711.27. Automakers led the surge, with Honda Motor rising 1.4 percent while Toyota Motor and Subaru both gained around 3 percent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback